Showing results (211-220 of 326) with videos related to
Sort By:
Pageof 33
Neuro-Oncology Advances|January 6, 2025
Prognostic factors for overall survival in elderly patients with glioblastoma: Analysis of the pooled NOA-08 and Nordic trials with the CCTG-EORTC (CE.6) trialAnnika Malmström, Felix B Oppong, Christopher J O Callaghan, et al.Oncoimmunology|January 27, 2017
The stress kinase GCN2 does not mediate suppression of antitumor T cell responses by tryptophan catabolism in experimental melanomasJana K Sonner, Katrin Deumelandt, Martina Ott, et al.Oncotarget|March 25, 2014
Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHRUlrike M Litzenburger, Christiane A Opitz, Felix Sahm, et al.Nature Medicine|May 10, 2016
Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptorVeit Rothhammer, Ivan D Mascanfroni, Lukas Bunse, et al.Journal of Neurochemistry|July 1, 2014
Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity?Dieter Lemke, Markus Weiler, Jonas Blaes, et al.NPJ Digital Medicine|April 25, 2025
Machine learning-based forecasting of daily acute ischemic stroke admissions using weather dataNandhini Santhanam, Hee E Kim, David Rügamer, et al.Biorxiv : the Preprint Server for Biology|November 26, 2025
Employing RNA editing to engineer personalized tumor-specific neoantigens (editopes)Riccardo Pecori, Beatrice Casati, Rona Merdler-Rabinowicz, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2017
Synovial Fibroblasts Selectively Suppress Th1 Cell Responses through IDO1-Mediated Tryptophan CatabolismLars-Oliver Tykocinski, Anna M Lauffer, Antonia Bohnen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2014
A phase II, randomized, study of weekly APG101+reirradiation versus reirradiation in progressive glioblastomaWolfgang Wick, Harald Fricke, Klaus Junge, et al.Molecular & Cellular Proteomics : MCP|August 7, 2024
optiPRM: A Targeted Immunopeptidomics LC-MS Workflow With Ultra-High Sensitivity for the Detection of Mutation-Derived Tumor Neoepitopes From Limited Input MaterialMogjiborahman Salek, Jonas D Förster, Jonas P Becker, et al.Pageof 33